Search Results 11-20 of 17655 for Thromboembolism

  1. Blood clots Causes - Mayo Clinic

    What is venous thromboembolism? Centers for Disease Control and Prevention. https://www.cdc.gov/ncbddd/dvt/facts.html. Accessed April 23, 2023.

  2. Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism - Mayo Clinic

    ... thromboembolism. Venous thromboembolism is a condition in which a blood clot forms in a vein and then breaks off and moves through the bloodstream. Patients ...

  3. A Study to Identify Genes Responsible for Venous Thromboembolism (VTE) in Families - Mayo Clinic

    The purpose of this study is to identify susceptibility genes for venous thromboembolism (VTE) using conventional and novel genetic-epidemiologic methods in ...

  4. Blood clots Causes - Mayo Clinic

    What is venous thromboembolism? Centers for Disease Control and Prevention. https://www.cdc.gov/ncbddd/dvt/facts.html. Accessed April 23, 2023.

  5. Pulmonary Embolism Clinical Trials - Mayo Clinic Research

    ... thromboembolism events and related death after hospital discharge in high-risk, medically ill patients. A Registry for United States Patients with Chronic ...

  6. Thrombophlebitis - Symptoms & causes - Mayo Clinic

    What is venous thromboembolism? Centers for Disease Control and Prevention. https://www.cdc.gov/ncbddd/dvt/facts.html. Accessed Sept. 11, 2021. Diagnosis ...

  7. VTE and implications for trauma care - Mayo Clinic

    One role of trauma professionals is venous thromboembolism (VTE) prevention in patients who have experienced traumatic injury. Read about factors that put ...

  8. A Study Of Rivaroxaban (JNJ-39039039) On The Venous Thromboembolic Risk In Post-Hospital Discharge Patients - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of rivaroxaban compared with placebo in the prevention of symptomatic venous thromboembolism ...

  9. A Study to Evaluate the Effectiveness and Safety of Rivaroxaban as Prophylaxis Treatment for Venous Thromboembolism (VTE) in Ambulatory Cancer Patients - Mayo Clinic

    A Study to Evaluate the Effectiveness and Safety of Rivaroxaban as Prophylaxis Treatment for Venous Thromboembolism (VTE) in Ambulatory Cancer Patients.

  10. A Study Of The Effectiveness And Safety Of Rivaroxaban On Venous Thromboembolic Risk In Patients Following Hospital Discharge - Mayo Clinic

    ... thromboembolism events and related death after hospital discharge in high-risk, medically ill patients. Participation eligibility. Participant eligibility ...